14 February 2017

By Dr Wendy Winnall - PCFA Research Team

Which is best: surgery, radiotherapy or active surveillance?

Each year, ASCO publishes Clinical Cancer Advances, describing the most promising cancer research advances of the previous 12 months. Clinical Cancer Advances 2017 includes a prostate cancer section describing the ProtecT trial. This study compared outcomes for three treatment options for localised prostate cancer: surgery, radiotherapy and active surveillance.

To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.


Join Online Community Button